Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Micardis 40mg

This product is the most expensive of its product family


Contraindicated
Reproductive toxicity in animals

Not recommended
Micardis 40mg :
Type Medicine Authorised
Originator B
Agent Mersaco
Distributor Mersaco
Laboratory Boehringer Ingelheim
Responsible Party Boehringer Ingelheim Pharma GmbH & Co KG
Origin Germany
Manufacturer Rottendorf Pharma GmbH
Origin Germany
ATC C09CA07

Your comment will appear shortly after approval

Micardis 40mg :

Revision Date : 04/09/2014


Effect Frequency
Abdominal pain Uncommon
Anaemia Uncommon
Anaphylactic reactions Rare
Angioedema (Angioneurotic oedema) (Quincke oedema) Rare
Anxiety Rare
Arthralgia (Pain joint) (Joint ache) Rare
Back pain Uncommon
Blood creatine phosphokinase increased Rare
Blood creatinine increased Uncommon
Blood uric acid increased Rare
Bradycardia Uncommon
Chest pain Uncommon
Cough Uncommon
Cystitis Uncommon
Depression Uncommon
Diarrhoea (Diarrhea) Uncommon
Drug eruption Rare
Dry mouth (Xerostomia) Rare
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) Rare
Dyspepsia Uncommon
Dyspnoea (dyspnea) Uncommon
Eczema Rare
Eosinophilia Rare
Erythema Rare
Flatulence Uncommon
Haemoglobin decreased Rare
Hepatic enzyme increased Rare
Hepatic function abnormal Rare
Hyperhidrosis Uncommon
Hyperkalaemia Uncommon
Hypersensitivity Rare
Hypoglycaemia Rare
Hypotension Uncommon
Influenza-like illness Rare
Insomnia Uncommon
Interstitial pneumonitis Very rare
Liver disorder Rare
Muscle spasms Uncommon
Myalgia Uncommon
Orthostatic hypotension Uncommon
Pain in extremity (Pain in limb) Rare
Pharyngitis Uncommon
Pruritus Uncommon
Renal failure acute (Acute renal insufficiency) (Kidney failure acute) (Renal insufficiency acute) Uncommon
Renal impairment Uncommon
Sciatica Uncommon
Sepsis (Systemic infection) (Sepsis state) Rare
Sinusitis Uncommon
Skin rash Uncommon
Somnolence Rare
Stomach discomfort Rare
Syncope Uncommon
Tachycardia Rare
Tendon pain Rare
Thrombocytopenia (Thrombopenia) Rare
Toxic skin eruption Rare
Upper respiratory tract infection Uncommon
Urinary tract infection Uncommon
Urticaria Rare
Vertigo Uncommon
Visual disturbance Rare
Vomiting Uncommon
Weakness Uncommon

Different Units By MoH Code

Revision Date : 01/05/2013

Micardis 40mg  MoH 2265 :
Form Tablet
Packaging Blisters (Al/Al)
Package Size Box of 28
Strength 40mg
Storage Condition <30°C Away from moisture
Public Price 760614.86 L.L.
Stratum A2
NSSF ✔
Quarantine ✘
Reg. Number 974489/00
Submission date 01/01/2000
Registration Year 2002


Price Comparison

● Country: Switzerland
● Package Size: 28
● Public Price: 37.6 CHF ( 3,888,592.00 LBP )
● Pack size unit used: 28
● Cost/Unit: 1,3429 CHF ( 103,420.00 LBP )
● Exfactory Price: 18.45 CHF
● Pricing Date: 04/04/2021
● Type: Medicine Authorised

● Country: Qatar
● Package Size: 28
● Public Price: 98 QAR ( 2,406,684.00 LBP )
● Pack size unit used: 28
● Cost/Unit: 3,5 QAR ( 73,674.00 LBP )
● Pharmacy Price: 80.70248602 QAR ( 1981891.6516792 LBP )
● Pricing Date: 28/01/2021
● Type: Medicine Authorised

● Country: Abu Dhabi
● Package Size: 28
● Public Price: 97 AED ( 2,343,617.00 LBP )
● Pack size unit used: 28
● Cost/Unit: 3,4643 AED ( 72,483.00 LBP )
● Pharmacy Price: 78.21 AED ( 1889631.81 LBP )
● Pricing Date: 27/01/2021
● Type: Medicine Authorised

● Country: UAE
● Package Size: 28's (7's Blister x 4)
● Public Price: 97 AED ( 2,343,617.00 LBP )
● Pack size unit used: 28
● Cost/Unit: 3,4643 AED ( 72,483.00 LBP )
● Pharmacy Price: 78.21 AED ( 1889631.81 LBP )
● Pricing Date: 21/08/2019
● Type: Medicine Authorised

● Country: Iceland
● Package Size: 98
● Public Price: 10526 ISK ( 6,789,270.00 LBP )
● Pack size unit used: 98
● Cost/Unit: 107,4082 ISK ( 69,015.00 LBP )
● Pharmacy Price: 6585 ISK ( 4247325 LBP )
● Reference: Icelandic Medicines Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

● Country: Norway
● Package Size: 28
● Public Price: 196.1 NOK ( 1,589,194.40 LBP )
● Pack size unit used: 28
● Cost/Unit: 7,0036 NOK ( 56,728.00 LBP )
● Pharmacy Price: 125.39 NOK ( 1016160.56 LBP )
● Reference: Norwegian Medicine Agency
● Pricing Date: 01/04/2020
● Type: Medicine Withdrawn

● Country: KSA
● Package Size: 28
● Public Price: 56.25 SAR ( 1,329,750.00 LBP )
● Pack size unit used: 28
● Cost/Unit: 2,0089 SAR ( 47,280.00 LBP )
● Reference: sfda
● Pricing Date: 16/01/2021
● Type: Medicine Authorised

● Country: Tunisia
● Package Size: Boîte de 28
● Public Price: 32.97 TND ( 951,679.05 LBP )
● Pack size unit used: 28
● Cost/Unit: 1,1775 TND ( 28,865.00 LBP )
● Pricing Date: 04/02/2019
● Type: Medicine Authorised

● Country: Lebanon
● Form: Tablet
● Package Size: Box of 28
● Public Price: 760614.86 LBP ( 760,614.86 LBP )
● Pack size unit used: 28
● Cost/Unit: 27164,82 LBP ( 27,164.00 LBP )
● Pricing Date: 13/06/2024

● Country: Sweden
● Package Size: 28
● Public Price: 98.45 SEK ( 827,767.60 LBP )
● Pack size unit used: 28
● Cost/Unit: 3,5161 SEK ( 25,224.00 LBP )
● Pharmacy Price: 47.04 SEK ( 395512.32 LBP )
● Pricing Date: 23/04/2020
● Type: Medicine Authorised

● Country: Denmark
● Package Size: 98
● Public Price: 148.25 DKK ( 1,923,692.00 LBP )
● Pack size unit used: 98
● Cost/Unit: 1,5128 DKK ( 12,976.00 LBP )
● Pharmacy Price: 105.15 DKK ( 1364426.4 LBP )
● Reference: Danish Medicine Agency
● Pricing Date: 19/05/2021
● Type: Medicine Authorised

● Country: Bahrain
● Package Size: 28
● Public Price: 7.54 BHD ( 1,792,514.36 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,2693 BHD ( 0.00 LBP )
● Reference: nhra
● Pricing Date: 09/02/2021
● Type: Medicine Authorised

● Country: The Netherlands
● Package Size: 28
● Public Price: 14.72 EUR ( 1,426,014.72 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,5257 EUR ( 0.00 LBP )
● Pharmacy Price: 7.72 EUR ( 747882.72 LBP )
● Reference: Zorginstituut Nederland
● Pricing Date: 15/06/2019
● Type: Medicine Authorised

● Country: Germany
● Package Size: 28
● Public Price: 83.07 EUR ( 8,047,489.32 LBP )
● Pack size unit used: 98
● Cost/Unit: 0,8477 EUR ( 0.00 LBP )
● Pricing Date: 15/05/2021
● Type: Medicine Authorised

● Country: Kuweit
● Package Size: Boîte de 28
● Public Price: 4.73 KWD ( 1,388,638.13 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,1689 KWD ( 0.00 LBP )
● Pharmacy Price: 3.99 KWD ( 1171388.19 LBP )
● Pricing Date: 07/02/2021
● Type: Medicine Authorised

● Country: Greece
● Package Size: 28
● Public Price: 6.02 EUR ( 583,193.52 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,215 EUR ( 0.00 LBP )
● Exfactory Price: 4.17 EUR
● Pharmacy Price: 4.37 EUR ( 423348.12 LBP )
● Reference: National Organization for Medicines
● Pricing Date: 25/02/2021
● Type: Medicine Authorised

● Country: Finland
● Package Size: 28
● Public Price: 12.55 EUR ( 1,215,793.80 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,4482 EUR ( 0.00 LBP )
● Reference: Kela
● Pricing Date: 22/04/2021
● Type: Medicine Non Marketed

● Country: Portugal
● Package Size: 28
● Public Price: 8.12 EUR ( 786,633.12 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,29 EUR ( 0.00 LBP )
● Reference: Autoridade Nacional do Medicamento e Produtos de Saúde
● Pricing Date: 22/04/2019
● Type: Medicine Authorised

● Country: France
● Package Size: 30
● Public Price: 6.31 EUR ( 611,287.56 LBP )
● Pack size unit used: 30
● Cost/Unit: 0,2103 EUR ( 0.00 LBP )
● Reference: ansm
● Pricing Date: 15/05/2021
● Type: Medicine Authorised

● Country: Spain
● Package Size: 28
● Public Price: 9.99 EUR ( 967,791.24 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,3568 EUR ( 0.00 LBP )
● Pharmacy Price: 6.4 EUR ( 620006.4 LBP )
● Reference: Agencia Española de Medicamentos y Productos Sanitarios
● Pricing Date: 06/05/2021
● Type: Medicine Authorised

● Country: Italy
● Package Size: 28UNITA
● Public Price: 8.19 EUR ( 793,414.44 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,2925 EUR ( 0.00 LBP )
● Pricing Date: 15/01/2021
● Type: Medicine Authorised

● Country: Ireland
● Package Size: 28
● Public Price: 3.64 EUR ( 352,628.64 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,13 EUR ( 0.00 LBP )
● Exfactory Price: 3 EUR
● Pricing Date: 09/10/2020
● Type: Medicine Authorised

● Country: Cyprus
● Package Size: 28 TABS
● Public Price: 12.37 EUR ( 1,198,356.12 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,4418 EUR ( 0.00 LBP )
● Reference: Cyprus Minister of Health
● Pricing Date: 24/03/2021
● Type: Medicine Authorised

● Country: Belgium
● Package Size: 28
● Public Price: 13.43 EUR ( 1,301,044.68 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,4796 EUR ( 0.00 LBP )
● Reference: cbip
● Pricing Date: 27/11/2020
● Type: Medicine Authorised

● Country: Oman
● Package Size: 28
● Public Price: 6.07 OMR ( 1,400,555.38 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,2168 OMR ( 0.00 LBP )
● Pricing Date: 19/02/2021
● Type: Medicine Authorised

● Country: Jordan
● Package Size: 28
● Public Price: 7.54 JOD ( 944,166.34 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,2693 JOD ( 0.00 LBP )
● Pharmacy Price: 5.75 JOD ( 720020.75 LBP )
● Reference: JFDA
● Pricing Date: 02/01/2021
● Type: Medicine Authorised

● Country: UK
● Package Size: 28
● Public Price: 13.61 GBP ( 1,546,762.89 LBP )
● Pack size unit used: 28
● Cost/Unit: 0,4861 GBP ( 0.00 LBP )
● Reference: DMD
● Pricing Date: 08/03/2021
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Note

Essential hypertension : (Adults)
● Cost/Unit: 1,3429 CHF ( 103,420.00 LBP )
● Cost/Day: 1,34 CHF ( 103,420.00 LBP )
● Cost/Month: 40,2 CHF ( 4,136,800.00 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 1,3429 CHF ( 103,420.00 LBP )
● Cost/Day: 2,69 CHF ( 206,840.00 LBP )
● Cost/Month: 80,7 CHF ( 8,273,600.00 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 1,3429 CHF ( 103,420.00 LBP )
● Cost/Day: 2,69 CHF ( 206,840.00 LBP )
● Cost/Month: 80,7 CHF ( 8,273,600.00 LBP )
Essential hypertension : (Adults)
● Cost/Unit: 3,5 QAR ( 73,674.00 LBP )
● Cost/Day: 3,5 QAR ( 73,674.00 LBP )
● Cost/Month: 105 QAR ( 2,578,590.00 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 3,5 QAR ( 73,674.00 LBP )
● Cost/Day: 7 QAR ( 171,906.00 LBP )
● Cost/Month: 210 QAR ( 5,157,180.00 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 3,5 QAR ( 73,674.00 LBP )
● Cost/Day: 7 QAR ( 171,906.00 LBP )
● Cost/Month: 210 QAR ( 5,157,180.00 LBP )
Essential hypertension : (Adults)
● Cost/Unit: 3,4643 AED ( 72,483.00 LBP )
● Cost/Day: 3,46 AED ( 72,483.00 LBP )
● Cost/Month: 103,8 AED ( 2,488,583.00 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 3,4643 AED ( 72,483.00 LBP )
● Cost/Day: 6,93 AED ( 144,966.00 LBP )
● Cost/Month: 207,9 AED ( 5,001,327.00 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 3,4643 AED ( 72,483.00 LBP )
● Cost/Day: 6,93 AED ( 144,966.00 LBP )
● Cost/Month: 207,9 AED ( 5,001,327.00 LBP )
Essential hypertension : (Adults)
● Cost/Unit: 3,4643 AED ( 72,483.00 LBP )
● Cost/Day: 3,46 AED ( 72,483.00 LBP )
● Cost/Month: 103,8 AED ( 2,488,583.00 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 3,4643 AED ( 72,483.00 LBP )
● Cost/Day: 6,93 AED ( 144,966.00 LBP )
● Cost/Month: 207,9 AED ( 5,001,327.00 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 3,4643 AED ( 72,483.00 LBP )
● Cost/Day: 6,93 AED ( 144,966.00 LBP )
● Cost/Month: 207,9 AED ( 5,001,327.00 LBP )
Essential hypertension : (Adults)
● Cost/Unit: 107,4082 ISK ( 69,015.00 LBP )
● Cost/Day: 107,41 ISK ( 69,015.00 LBP )
● Cost/Month: 3222,3 ISK ( 2,078,190.00 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 107,4082 ISK ( 69,015.00 LBP )
● Cost/Day: 214,82 ISK ( 138,030.00 LBP )
● Cost/Month: 6444,6 ISK ( 4,156,380.00 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 107,4082 ISK ( 69,015.00 LBP )
● Cost/Day: 214,82 ISK ( 138,030.00 LBP )
● Cost/Month: 6444,6 ISK ( 4,156,380.00 LBP )
Essential hypertension : (Adults)
● Cost/Unit: 7,0036 NOK ( 56,728.00 LBP )
● Cost/Day: 7 NOK ( 56,728.00 LBP )
● Cost/Month: 210 NOK ( 1,701,840.00 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 7,0036 NOK ( 56,728.00 LBP )
● Cost/Day: 14,01 NOK ( 113,456.00 LBP )
● Cost/Month: 420,3 NOK ( 3,403,680.00 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 7,0036 NOK ( 56,728.00 LBP )
● Cost/Day: 14,01 NOK ( 113,456.00 LBP )
● Cost/Month: 420,3 NOK ( 3,403,680.00 LBP )
Essential hypertension : (Adults)
● Cost/Unit: 2,0089 SAR ( 47,280.00 LBP )
● Cost/Day: 2,01 SAR ( 47,280.00 LBP )
● Cost/Month: 60,3 SAR ( 1,418,400.00 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 2,0089 SAR ( 47,280.00 LBP )
● Cost/Day: 4,02 SAR ( 94,560.00 LBP )
● Cost/Month: 120,6 SAR ( 2,836,800.00 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 2,0089 SAR ( 47,280.00 LBP )
● Cost/Day: 4,02 SAR ( 94,560.00 LBP )
● Cost/Month: 120,6 SAR ( 2,836,800.00 LBP )
Essential hypertension : (Adults)
● Cost/Unit: 1,1775 TND ( 28,865.00 LBP )
● Cost/Day: 1,18 TND ( 28,865.00 LBP )
● Cost/Month: 35,4 TND ( 1,010,275.00 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 1,1775 TND ( 28,865.00 LBP )
● Cost/Day: 2,36 TND ( 57,730.00 LBP )
● Cost/Month: 70,8 TND ( 2,020,550.00 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 1,1775 TND ( 28,865.00 LBP )
● Cost/Day: 2,36 TND ( 57,730.00 LBP )
● Cost/Month: 70,8 TND ( 2,020,550.00 LBP )
Essential hypertension : (Adults)
● Cost/Unit: 27164,82 LBP ( 27,164.00 LBP )
● Cost/Day: 27164,82 LBP ( 27,164.00 LBP )
● Cost/Month: 814944,6 LBP ( 814,944.00 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 27164,82 LBP ( 27,164.00 LBP )
● Cost/Day: 54329,64 LBP ( 54,329.00 LBP )
● Cost/Month: 1629889,2 LBP ( 1,629,889.00 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 27164,82 LBP ( 27,164.00 LBP )
● Cost/Day: 54329,64 LBP ( 54,329.00 LBP )
● Cost/Month: 1629889,2 LBP ( 1,629,889.00 LBP )
Essential hypertension : (Adults)
● Cost/Unit: 3,5161 SEK ( 25,224.00 LBP )
● Cost/Day: 3,52 SEK ( 25,224.00 LBP )
● Cost/Month: 105,6 SEK ( 882,840.00 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 3,5161 SEK ( 25,224.00 LBP )
● Cost/Day: 7,03 SEK ( 58,856.00 LBP )
● Cost/Month: 210,9 SEK ( 1,765,680.00 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 3,5161 SEK ( 25,224.00 LBP )
● Cost/Day: 7,03 SEK ( 58,856.00 LBP )
● Cost/Month: 210,9 SEK ( 1,765,680.00 LBP )
Essential hypertension : (Adults)
● Cost/Unit: 1,5128 DKK ( 12,976.00 LBP )
● Cost/Day: 1,51 DKK ( 12,976.00 LBP )
● Cost/Month: 45,3 DKK ( 583,920.00 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 1,5128 DKK ( 12,976.00 LBP )
● Cost/Day: 3,03 DKK ( 38,928.00 LBP )
● Cost/Month: 90,9 DKK ( 1,167,840.00 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 1,5128 DKK ( 12,976.00 LBP )
● Cost/Day: 3,03 DKK ( 38,928.00 LBP )
● Cost/Month: 90,9 DKK ( 1,167,840.00 LBP )
Essential hypertension : (Adults)
● Cost/Unit: 0,215 EUR ( 0.00 LBP )
● Cost/Day: 0,22 EUR ( 0.00 LBP )
● Cost/Month: 6,6 EUR ( 581,256.00 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 0,215 EUR ( 0.00 LBP )
● Cost/Day: 0,43 EUR ( 0.00 LBP )
● Cost/Month: 12,9 EUR ( 1,162,512.00 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 0,215 EUR ( 0.00 LBP )
● Cost/Day: 0,43 EUR ( 0.00 LBP )
● Cost/Month: 12,9 EUR ( 1,162,512.00 LBP )
Essential hypertension : (Adults)
● Cost/Unit: 0,8477 EUR ( 0.00 LBP )
● Cost/Day: 0,85 EUR ( 0.00 LBP )
● Cost/Month: 25,5 EUR ( 2,421,900.00 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 0,8477 EUR ( 0.00 LBP )
● Cost/Day: 1,7 EUR ( 96,876.00 LBP )
● Cost/Month: 51 EUR ( 4,940,676.00 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 0,8477 EUR ( 0.00 LBP )
● Cost/Day: 1,7 EUR ( 96,876.00 LBP )
● Cost/Month: 51 EUR ( 4,940,676.00 LBP )
Essential hypertension : (Adults)
● Cost/Unit: 0,5257 EUR ( 0.00 LBP )
● Cost/Day: 0,53 EUR ( 0.00 LBP )
● Cost/Month: 15,9 EUR ( 1,453,140.00 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 0,5257 EUR ( 0.00 LBP )
● Cost/Day: 1,05 EUR ( 96,876.00 LBP )
● Cost/Month: 31,5 EUR ( 3,003,156.00 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 0,5257 EUR ( 0.00 LBP )
● Cost/Day: 1,05 EUR ( 96,876.00 LBP )
● Cost/Month: 31,5 EUR ( 3,003,156.00 LBP )
Essential hypertension : (Adults)
● Cost/Unit: 0,4796 EUR ( 0.00 LBP )
● Cost/Day: 0,48 EUR ( 0.00 LBP )
● Cost/Month: 14,4 EUR ( 1,356,264.00 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 0,4796 EUR ( 0.00 LBP )
● Cost/Day: 0,96 EUR ( 0.00 LBP )
● Cost/Month: 28,8 EUR ( 2,712,528.00 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 0,4796 EUR ( 0.00 LBP )
● Cost/Day: 0,96 EUR ( 0.00 LBP )
● Cost/Month: 28,8 EUR ( 2,712,528.00 LBP )
Essential hypertension : (Adults)
● Cost/Unit: 0,2693 BHD ( 0.00 LBP )
● Cost/Day: 0,27 BHD ( 0.00 LBP )
● Cost/Month: 8,1 BHD ( 1,901,872.00 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 0,2693 BHD ( 0.00 LBP )
● Cost/Day: 0,54 BHD ( 0.00 LBP )
● Cost/Month: 16,2 BHD ( 3,803,744.00 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 0,2693 BHD ( 0.00 LBP )
● Cost/Day: 0,54 BHD ( 0.00 LBP )
● Cost/Month: 16,2 BHD ( 3,803,744.00 LBP )
Essential hypertension : (Adults)
● Cost/Unit: 0,4418 EUR ( 0.00 LBP )
● Cost/Day: 0,44 EUR ( 0.00 LBP )
● Cost/Month: 13,2 EUR ( 1,259,388.00 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 0,4418 EUR ( 0.00 LBP )
● Cost/Day: 0,88 EUR ( 0.00 LBP )
● Cost/Month: 26,4 EUR ( 2,518,776.00 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 0,4418 EUR ( 0.00 LBP )
● Cost/Day: 0,88 EUR ( 0.00 LBP )
● Cost/Month: 26,4 EUR ( 2,518,776.00 LBP )
Essential hypertension : (Adults)
● Cost/Unit: 0,13 EUR ( 0.00 LBP )
● Cost/Day: 0,13 EUR ( 0.00 LBP )
● Cost/Month: 3,9 EUR ( 290,628.00 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 0,13 EUR ( 0.00 LBP )
● Cost/Day: 0,26 EUR ( 0.00 LBP )
● Cost/Month: 7,8 EUR ( 678,132.00 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 0,13 EUR ( 0.00 LBP )
● Cost/Day: 0,26 EUR ( 0.00 LBP )
● Cost/Month: 7,8 EUR ( 678,132.00 LBP )
Essential hypertension : (Adults)
● Cost/Unit: 0,4861 GBP ( 0.00 LBP )
● Cost/Day: 0,49 GBP ( 0.00 LBP )
● Cost/Month: 14,7 GBP ( 1,591,086.00 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 0,4861 GBP ( 0.00 LBP )
● Cost/Day: 0,97 GBP ( 0.00 LBP )
● Cost/Month: 29,1 GBP ( 3,295,821.00 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 0,4861 GBP ( 0.00 LBP )
● Cost/Day: 0,97 GBP ( 0.00 LBP )
● Cost/Month: 29,1 GBP ( 3,295,821.00 LBP )
Essential hypertension : (Adults)
● Cost/Unit: 0,2925 EUR ( 0.00 LBP )
● Cost/Day: 0,29 EUR ( 0.00 LBP )
● Cost/Month: 8,7 EUR ( 775,008.00 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 0,2925 EUR ( 0.00 LBP )
● Cost/Day: 0,58 EUR ( 0.00 LBP )
● Cost/Month: 17,4 EUR ( 1,646,892.00 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 0,2925 EUR ( 0.00 LBP )
● Cost/Day: 0,58 EUR ( 0.00 LBP )
● Cost/Month: 17,4 EUR ( 1,646,892.00 LBP )
Essential hypertension : (Adults)
● Cost/Unit: 0,2693 JOD ( 0.00 LBP )
● Cost/Day: 0,27 JOD ( 0.00 LBP )
● Cost/Month: 8,1 JOD ( 1,001,768.00 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 0,2693 JOD ( 0.00 LBP )
● Cost/Day: 0,54 JOD ( 0.00 LBP )
● Cost/Month: 16,2 JOD ( 2,003,536.00 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 0,2693 JOD ( 0.00 LBP )
● Cost/Day: 0,54 JOD ( 0.00 LBP )
● Cost/Month: 16,2 JOD ( 2,003,536.00 LBP )
Essential hypertension : (Adults)
● Cost/Unit: 0,1689 KWD ( 0.00 LBP )
● Cost/Day: 0,17 KWD ( 0.00 LBP )
● Cost/Month: 5,1 KWD ( 1,467,905.00 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 0,1689 KWD ( 0.00 LBP )
● Cost/Day: 0,34 KWD ( 0.00 LBP )
● Cost/Month: 10,2 KWD ( 2,935,810.00 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 0,1689 KWD ( 0.00 LBP )
● Cost/Day: 0,34 KWD ( 0.00 LBP )
● Cost/Month: 10,2 KWD ( 2,935,810.00 LBP )
Essential hypertension : (Adults)
● Cost/Unit: 0,3568 EUR ( 0.00 LBP )
● Cost/Day: 0,36 EUR ( 0.00 LBP )
● Cost/Month: 10,8 EUR ( 968,760.00 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 0,3568 EUR ( 0.00 LBP )
● Cost/Day: 0,71 EUR ( 0.00 LBP )
● Cost/Month: 21,3 EUR ( 2,034,396.00 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 0,3568 EUR ( 0.00 LBP )
● Cost/Day: 0,71 EUR ( 0.00 LBP )
● Cost/Month: 21,3 EUR ( 2,034,396.00 LBP )
Essential hypertension : (Adults)
● Cost/Unit: 0,2168 OMR ( 0.00 LBP )
● Cost/Day: 0,22 OMR ( 0.00 LBP )
● Cost/Month: 6,6 OMR ( 1,384,404.00 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 0,2168 OMR ( 0.00 LBP )
● Cost/Day: 0,43 OMR ( 0.00 LBP )
● Cost/Month: 12,9 OMR ( 2,768,808.00 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 0,2168 OMR ( 0.00 LBP )
● Cost/Day: 0,43 OMR ( 0.00 LBP )
● Cost/Month: 12,9 OMR ( 2,768,808.00 LBP )
Essential hypertension : (Adults)
● Cost/Unit: 0,2103 EUR ( 0.00 LBP )
● Cost/Day: 0,21 EUR ( 0.00 LBP )
● Cost/Month: 6,3 EUR ( 581,256.00 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 0,2103 EUR ( 0.00 LBP )
● Cost/Day: 0,42 EUR ( 0.00 LBP )
● Cost/Month: 12,6 EUR ( 1,162,512.00 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 0,2103 EUR ( 0.00 LBP )
● Cost/Day: 0,42 EUR ( 0.00 LBP )
● Cost/Month: 12,6 EUR ( 1,162,512.00 LBP )
Essential hypertension : (Adults)
● Cost/Unit: 0,29 EUR ( 0.00 LBP )
● Cost/Day: 0,29 EUR ( 0.00 LBP )
● Cost/Month: 8,7 EUR ( 775,008.00 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 0,29 EUR ( 0.00 LBP )
● Cost/Day: 0,58 EUR ( 0.00 LBP )
● Cost/Month: 17,4 EUR ( 1,646,892.00 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 0,29 EUR ( 0.00 LBP )
● Cost/Day: 0,58 EUR ( 0.00 LBP )
● Cost/Month: 17,4 EUR ( 1,646,892.00 LBP )
Essential hypertension : (Adults)
● Cost/Unit: 0,4482 EUR ( 0.00 LBP )
● Cost/Day: 0,45 EUR ( 0.00 LBP )
● Cost/Month: 13,5 EUR ( 1,259,388.00 LBP )
Reduction of myocardial infarction risk : (Adults)
● Cost/Unit: 0,4482 EUR ( 0.00 LBP )
● Cost/Day: 0,9 EUR ( 0.00 LBP )
● Cost/Month: 27 EUR ( 2,615,652.00 LBP )
Reduction of stroke risk : (Adults)
● Cost/Unit: 0,4482 EUR ( 0.00 LBP )
● Cost/Day: 0,9 EUR ( 0.00 LBP )
● Cost/Month: 27 EUR ( 2,615,652.00 LBP )
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info